论文信息 - Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer - 字舞流文

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

B. Monk | A. Oza | I. Vergote | S. Pignata | I. Ray-Coquard | J. Sehouli | C. Aghajanian | Susana Banerjee | N. Colombo | G. Kristensen | E. Kalbacher | D. Cibula | M. Mirza | C. Marth | E. Drill | M. Oehler | P. Vuylsteke | A. Westermann | A. Clamp | D. O’Malley | R. Berger | J. Farley | F. Hilpert | J. D. Del Campo | R. Grisham | I. Romero | K. Moore | G. Iyer | R. Coleman | C. Churruca